GHP Q4 2023 Building a Flexible, Partner-Centric Approach for the Future of Therapeutics In addition to its antibody discovery solutions, OmniAb possesses extensive biological capabilities focused on developing small molecule and antibody therapeutics for ion channels and transporters. Both ion channels and transporters are key components across a variety of biological processes, having broad therapeutic applicability in diverse areas such as cancer, pain, and metabolic, neurological, and infectious diseases, among others. The company has also successfully integrated several other capabilities such as antigen generation, in silico discovery and optimization tools, and high throughput screening technologies, therefore offering partners a wide-ranging antibody discovery and development solution. With this portfolio, OmniAb takes a tailored approach for every project, whether a partner wants to use OmniAb’s end-to-end discovery capabilities or combine specific technologies with their own internal workflows. To ensure that they continue to effectively serve the pharmaceutical and biotechnology companies of the future, OmniAb continues to expand its platform in order to push the frontiers of drug discovery technologies. This is done through internal investment in enabling technologies and potential strategic acquisitions. By broadening its capabilities in the antibody discovering continuum, OmniAb will be able to explore partnerships with new clients in new markets. OmniAb At-a-Glance As of September 30, 2023, OmniAb has 76 active partners with 314 active programs. 27 OmniAb-derived antibodies are in clinical development, one is under regulatory review, and three are approved products by OmniAb partners. The company currently has approximately 109 full-time employees based in the United States, including 82 engaged in the fields of R&D; 37 members of the R&D team have PhDs. The company recognizes and takes care of its employees in a variety of ways, offering competitive pay, recognition, and an extensive benefit program. Moreover, the business has established a host of important initiatives dedicated to further employee and community engagement around meaningful endeavors advancing women in science, awareness about environmental issues, and diversity, equity, and inclusion. Contact: Business Development, [email protected] Company: OmniAb, Inc. Web Address: https://www.omniab.com/
RkJQdWJsaXNoZXIy MTUyMDQwMA==